ConferencePoster
 (2024)

Association of biomarkers with response to coformulated vibostolimab/pembrolizumab (vibo/pembro) in metastatic cervical cancer (CC): Exploratory analysis from the phase II KEYVIBE-005 study

Tourneau, C Le; Rojas, CI; Leary, A; Yonemori, K; Lugowska, I; Tosi, D; Ghiringhelli, F; Caglevic, C; Yanez, EP; Perets, R; Rha, SY; Salman, P et al